From Metabolically Healthy Obesity to Metabolically Unhealthy Obesity Populations: Decreased Bone Turnover Bioactivity

References

• Liu J, Zhang L, Fu J, Wang Q, Wang G. Circulating prolactin level is increased in metabolically healthy obesity. Endocr Connect. 2021;10(4):484–491. doi:10.1530/EC-21-0040
   PubMed Web of Science ®Google Scholar
• Bluher M. Metabolically healthy obesity. Endocr Rev. 2020;41(3):bnaa004. doi:10.1210/endrev/bnaa004
   PubMed Web of Science ®Google Scholar
• Stefan N, Haring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1(2):152–162. doi:10.1016/S2213-8587(13)70062-7
   PubMed Web of Science ®Google Scholar
• Janicka A, Wren TA, Sanchez MM, et al. Fat mass is not beneficial to bone in adolescents and young adults. J Clin Endocrinol Metab. 2007;92(1):143–147. doi:10.1210/jc.2006-0794
   PubMed Web of Science ®Google Scholar
• Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab. 2007;92(5):1640–1646. doi:10.1210/jc.2006-0572
   PubMed Web of Science ®Google Scholar
• Sukumar D, Schlussel Y, Riedt CS, Gordon C, Stahl T, Shapses SA. Obesity alters cortical and trabecular bone density and geometry in women. Osteoporos Int. 2011;22(2):635–645. doi:10.1007/s00198-010-1305-3
   PubMed Web of Science ®Google Scholar
• De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16(11):1330–1338. doi:10.1007/s00198-005-1863-y
   PubMed Web of Science ®Google Scholar
• Wetzsteon RJ, Petit MA, Macdonald HM, Hughes JM, Beck TJ, McKay HA. Bone structure and volumetric BMD in overweight children: a longitudinal study. J Bone Miner Res. 2008;23(12):1946–1953. doi:10.1359/jbmr.080810
   PubMed Web of Science ®Google Scholar
• Makovey J, Naganathan V, Sambrook P. Gender differences in relationships between body composition components, their distribution and bone mineral density: a cross-sectional opposite sex twin study. Osteoporos Int. 2005;16(12):1495–1505. doi:10.1007/s00198-005-1841-4
   PubMed Web of Science ®Google Scholar
• Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992;327(19):1350–1355. doi:10.1056/NEJM199211053271904
   PubMed Web of Science ®Google Scholar
• Kim HY, Choe JW, Kim HK, et al. Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men. Calcif Tissue Int. 2010;86(5):350–358. doi:10.1007/s00223-010-9347-2
   PubMed Web of Science ®Google Scholar
• Vigevano F, Gregori G, Colleluori G, et al. In men with obesity, T2DM is associated with poor trabecular microarchitecture and bone strength and low bone turnover. J Clin Endocrinol Metab. 2021;106(5):1362–1376. doi:10.1210/clinem/dgab061
   PubMed Web of Science ®Google Scholar
• Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016;118(11):1752–1770. doi:10.1161/CIRCRESAHA.115.306883
   PubMed Web of Science ®Google Scholar
• Gomez-Zorita S, Queralt M, Vicente MA, Gonzalez M, Portillo MP. Metabolically healthy obesity and metabolically obese normal weight: a review. J Physiol Biochem. 2021;77(1):175–189. doi:10.1007/s13105-020-00781-x
   PubMed Web of Science ®Google Scholar
• Mongraw-Chaffin M, Foster MC, Anderson CAM, et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2018;71(17):1857–1865. doi:10.1016/j.jacc.2018.02.055
   PubMed Web of Science ®Google Scholar
• Inker LA, Titan S. Measurement and estimation of GFR for use in clinical practice: core curriculum 2021. Am J Kidney Dis. 2021;78(5):736–749. doi:10.1053/j.ajkd.2021.04.016
   PubMed Web of Science ®Google Scholar
• Amato MC, Giordano C, Galia M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–922. doi:10.2337/dc09-1825
   PubMed Web of Science ®Google Scholar
• Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404. doi:10.1152/physrev.00033.2011
   PubMed Web of Science ®Google Scholar
• Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(9):956–966. doi:10.1177/2047487315623884
   PubMed Web of Science ®Google Scholar
• Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–769. doi:10.7326/0003-4819-159-11-201312030-00008
   PubMed Web of Science ®Google Scholar
• Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev. 2014;15(6):504–515. doi:10.1111/obr.12157
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Hamaguchi M, Tanaka M, Obora A, Kojima T, Fukui M. Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Res Clin Pract. 2018;12(1):4–15. doi:10.1016/j.orcp.2017.12.003
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Ross R, Despres JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715–725. doi:10.1016/S2213-8587(19)30084-1
   PubMed Web of Science ®Google Scholar
• Hwang YC, Hayashi T, Fujimoto WY, et al. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int J Obes. 2015;39(9):1365–1370. doi:10.1038/ijo.2015.75
   PubMed Web of Science ®Google Scholar
• Goday A, Calvo E, Vazquez LA, et al. Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study. BMC Public Health. 2016;16:248. doi:10.1186/s12889-016-2921-4
   PubMed Web of Science ®Google Scholar
• Stefan N, Schick F, Haring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26(2):292–300. doi:10.1016/j.cmet.2017.07.008
   PubMed Web of Science ®Google Scholar
• Stefan N, Haring HU, Schulze MB. Metabolically healthy obesity: the low-hanging fruit in obesity treatment? Lancet Diabetes Endocrinol. 2018;6(3):249–258. doi:10.1016/S2213-8587(17)30292-9
   PubMed Web of Science ®Google Scholar
• Chen TP, Lin WY, Chiang CH, Shen TH, Huang KC, Yang KC. Metabolically healthy obesity and risk of non-alcoholic fatty liver disease severity independent of visceral fat. J Gastroenterol Hepatol. 2021;36(10):2903–2910. doi:10.1111/jgh.15544
   PubMed Web of Science ®Google Scholar
• Farcas AD, Vonica CL, Golea A. Non-alcoholic fatty liver disease, bulb carotid intima-media thickness and obesity phenotypes: results of a prospective observational study. Med Ultrason. 2017;19(3):265–271. doi:10.11152/mu-1015
   PubMed Web of Science ®Google Scholar
• Dobson R, Burgess MI, Sprung VS, et al. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int J Obes. 2016;40(1):153–161. doi:10.1038/ijo.2015.151
   PubMed Web of Science ®Google Scholar
• Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 2004;30(6):569–572. doi:10.1016/s1262-3636(07)70156-8
   PubMed Web of Science ®Google Scholar
• Marques Loureiro L, Lessa S, Mendes R, Pereira S, Saboya CJ, Ramalho A. Does the metabolically healthy obese phenotype protect adults with class III obesity from biochemical alterations related to bone metabolism? Nutrients. 2019;11(9). doi:10.3390/nu11092125
   PubMed Web of Science ®Google Scholar
• Mirzababaei A, Mirzaei K, Khorrami-Nezhad L, Maghbooli Z, Keshavarz SA. Metabolically healthy/unhealthy components may modify bone mineral density in obese people. Arch Osteoporos. 2017;12(1):95. doi:10.1007/s11657-017-0381-9
   PubMed Web of Science ®Google Scholar
• Chen H, He Y, Wu D, et al. Bone marrow sFRP5 level is negatively associated with bone formation markers. Osteoporos Int. 2017;28(4):1305–1311. doi:10.1007/s00198-016-3873-3
   PubMed Web of Science ®Google Scholar
• D’Oronzo S, Brown J, Coleman R. The role of biomarkers in the management of bone-homing malignancies. J Bone Oncol. 2017;9:1–9. doi:10.1016/j.jbo.2017.09.001
   PubMed Web of Science ®Google Scholar
• Vilaca T, Evans A, Gossiel F, Paggiosi M, Eastell R, Walsh JS. Fat, adipokines, bone structure and bone regulatory factors associations in obesity. Eur J Endocrinol. 2022;187(6):743–750. doi:10.1530/EJE-22-0530
   PubMed Web of Science ®Google Scholar
• Andersson G, Ek-Rylander B, Hollberg K, et al. TRACP as an osteopontin phosphatase. J Bone Miner Res. 2003;18(10):1912–1915. doi:10.1359/jbmr.2003.18.10.1912
   PubMed Web of Science ®Google Scholar
• Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Vaananen HK. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab. 2006;52(9–10):499–509.
   PubMed Web of Science ®Google Scholar
• Cabral HW, Andolphi BF, Ferreira BV, et al. The use of biomarkers in clinical osteoporosis. Rev Assoc Med Bras. 2016;62(4):368–376. doi:10.1590/1806-9282.62.04.368
   PubMed Web of Science ®Google Scholar
• Marinho SM, Mafra D, Pelletier S, et al. In hemodialysis patients, intradialytic resistance exercise improves osteoblast function: a Pilot Study. J Ren Nutr. 2016;26(5):341–345. doi:10.1053/j.jrn.2016.03.002
   PubMed Web of Science ®Google Scholar
• Yu-Yahiro JA, Michael RH, Dubin NH, et al. Serum and urine markers of bone metabolism during the year after Hip fracture. J Am Geriatr Soc. 2001;49(7):877–883. doi:10.1046/j.1532-5415.2001.49177.x
   PubMed Web of Science ®Google Scholar
• Yerlikaya FH, Eryavuz Onmaz D. Inflammation and bone turnover markers in adult obesity. J Clin Densitom. 2022;25(4):470–474. doi:10.1016/j.jocd.2022.08.002
   PubMed Web of Science ®Google Scholar
• Bilinski WJ, Stefanska A, Szternel L, et al. Relationships between bone turnover markers and factors associated with metabolic syndrome in prepubertal girls and boys. Nutrients. 2022;14(6). doi:10.3390/nu14061205
   PubMed Web of Science ®Google Scholar
• Fuglsang-Nielsen R, Rakvaag E, Vestergaard P, et al. Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity. Bone. 2020;133:115230. doi:10.1016/j.bone.2020.115230
   PubMed Web of Science ®Google Scholar
• Garnero P, Delmas PD. Osteoporosis. Endocrinol Metab Clin North Am. 1997;26(4):913–936. doi:10.1016/s0889-8529(05)70287-5
   PubMed Web of Science ®Google Scholar
• Garnero P, Delmas PD. Biochemical markers of bone turnover. Applications for osteoporosis. Endocrinol Metab Clin North Am. 1998;27(2):303–323. doi:10.1016/s0889-8529(05)70007-4
   PubMed Web of Science ®Google Scholar
• Melo TL, Froeder L, Baia LDC, Heilberg IP. Bone turnover after bariatric surgery. Arch Endocrinol Metab. 2017;61(4):332–336. doi:10.1590/2359-3997000000279
   PubMed Web of Science ®Google Scholar
• Guo H, An Z, Wang N, et al. Diabetes mellitus type 2 patients with abdominal obesity are prone to osteodysfunction: a cross-sectional study. J Diabetes Res. 2023;2023:3872126. doi:10.1155/2023/3872126
   PubMed Web of Science ®Google Scholar
• Shepherd JA. Is osteoporosis an obesity paradox? J Clin Densitom. 2013;16(2):131–132. doi:10.1016/j.jocd.2012.05.002
   PubMed Web of Science ®Google Scholar
• Fassio A, Idolazzi L, Rossini M, et al. The obesity paradox and osteoporosis. Eat Weight Disord. 2018;23(3):293–302. doi:10.1007/s40519-018-0505-2
   PubMed Web of Science ®Google Scholar
• Ghezelbash F, Shirazi-Adl A, Plamondon A, Arjmand N, Parnianpour M. Obesity and obesity shape markedly influence spine biomechanics: a subject-specific risk assessment model. Ann Biomed Eng. 2017;45(10):2373–2382. doi:10.1007/s10439-017-1868-7
   PubMed Web of Science ®Google Scholar
• Liu CT, Broe KE, Zhou Y, et al. Visceral adipose tissue is associated with bone microarchitecture in the Framingham Osteoporosis Study. J Bone Miner Res. 2017;32(1):143–150. doi:10.1002/jbmr.2931
   PubMed Web of Science ®Google Scholar
• Pinar-Gutierrez A, Garcia-Fontana C, Garcia-Fontana B, Munoz-Torres M. Obesity and bone health: a complex relationship. Int J Mol Sci. 2022;23(15). doi:10.3390/ijms23158303
   PubMed Web of Science ®Google Scholar
• Hou J, He C, He W, Yang M, Luo X, Li C. Obesity and bone health: a complex link. Front Cell Dev Biol. 2020;8:600181. doi:10.3389/fcell.2020.600181
   PubMed Web of Science ®Google Scholar
• Kim YH, Nam GE, Cho KH, et al. Low bone mineral density is associated with dyslipidemia in South Korean men: the 2008–2010 Korean National Health and Nutrition Examination Survey. Endocr J. 2013;60(10):1179–1189. doi:10.1507/endocrj.ej13-0224
   PubMed Web of Science ®Google Scholar
• Papachristou DJ, Blair HC. Bone and high-density lipoprotein: the beginning of a beautiful friendship. World J Orthop. 2016;7(2):74–77. doi:10.5312/wjo.v7.i2.74
   PubMedGoogle Scholar
• Li S, Guo H, Liu Y, et al. Relationships of serum lipid profiles and bone mineral density in postmenopausal Chinese women. Clin Endocrinol. 2015;82(1):53–58. doi:10.1111/cen.12616
   PubMed Web of Science ®Google Scholar
• Ackert-Bicknell CL. HDL cholesterol and bone mineral density: is there a genetic link? Bone. 2012;50(2):525–533. doi:10.1016/j.bone.2011.07.002
   PubMed Web of Science ®Google Scholar
• Pagnotti GM, Styner M, Uzer G, et al. Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity. Nat Rev Endocrinol. 2019;15(6):339–355. doi:10.1038/s41574-019-0170-1
   PubMed Web of Science ®Google Scholar